Consensus STAAR Surgical Company Deutsche Boerse AG

Equities

SR3

US8523123052

Market Closed - Deutsche Boerse AG Other stock markets 11:33:25 28/06/2024 am IST			5-day change	1st Jan Change
43.48 ^EUR	+2.74%		+16.82%	+50.50%

21/06	STAAR Surgical Company Provides Information to the Shareholders	CI
12/06	Transcript : STAAR Surgical Company Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:00 AM

Evolution of the average Target Price on STAAR Surgical Company

Price target over the last 5 years

History of analyst recommendation changes

b786dbc0f2b0a094f3c0ab6b3ae6471.nqyqgG2S3Ut1p8mwERLEX2XjM37jvHAbAHcIvYJY9Oo.6vib4SbCpCpF_rr8en2TJwzSawaX7z9qcDpY9LA2nqvI-evvDui7IBTx8Q~ea6290408cae81f7b0ff51c3784f8619

Analyst Recommendations on STAAR Surgical Company

BTIG Upgrades STAAR Surgical to Buy From Neutral, Price Target is $46	11/06	MT
Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating	08/05	MT
Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating	08/05	MT
Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating	11/04	MT
Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating	08/04	MT
Stifel Upgrades STAAR Surgical to Buy From Hold, Raises Price Target to $50 From $30	11/03	MT
Mizuho Securities Adjusts Price Target on STAAR Surgical to $45 From $50, Keeps Buy Rating	28/02	MT
Piper Sandler Cuts STAAR Surgical Price Target to $33 From $40, Maintains Neutral Rating	27/02	MT
Needham Downgrades STAAR Surgical to Hold From Buy	05/12	MT
Morgan Stanley Initiates STAAR Surgical at Equal-Weight Rating With $35 Price Target	04/12	MT
Needham Adjusts Price Target on STAAR Surgical Company to $49 From $52, Keeps Buy Rating	02/11	MT
Stifel Lowers Price Target on STAAR Surgical to $40 From $45, Maintains Hold Rating	22/23/22	MT
Piper Sandler Adjusts Price Target on STAAR Surgical Company to $45 From $50, Keeps Neutral Rating	15/23/15	MT
Canaccord Genuity Adjusts STAAR Surgical Price Target to $43 From $48, Maintains Hold Rating	15/23/15	MT
Needham Cuts STAAR Surgical's Price Target to 52 From $54, Keeps Buy Rating	15/23/15	MT
Benchmark Downgrades STAAR Surgical to Hold From Buy	15/23/15	MT
Stifel Adjusts Price Target on STAAR Surgical Company to $45 From $50, Maintains Hold Rating	21/23/21	MT
Needham Adjusts Price Target on STAAR Surgical to $58 From $75, Maintains Buy Rating	03/23/03	MT
Canaccord Genuity Downgrades STAAR Surgical to Hold From Buy, Adjusts Price Target to $48 From $77	03/23/03	MT
ANALYST RECOMMENDATIONS : Ferrari, Qualcomm, Zillow, Roku, Southwest Airlines...	03/23/03
Stifel Cuts Price Target on STAAR Surgical to $55 From $60, Maintains Hold Rating	12/23/12	MT
William Blair Downgrades STAAR Surgical Company to Market Perform From Outperform	07/23/07	MT
Needham Adjusts Price Target on STAAR Surgical to $84 From $78, Maintains Buy Rating	04/23/04	MT
Piper Sandler Starts STAAR Surgical at Neutral With $65 Price Target	17/23/17	MT
ANALYST RECOMMENDATIONS : Biogen, Diageo, HP, Meta, Wolfspeed...	17/23/17

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

47.61 USD

Average target price

51.68 USD

Spread / Average Target

+8.55%

High Price Target

60 USD

Spread / Highest target

+26.02%

Low Price Target

40 USD

Spread / Lowest Target

-15.98%

Consensus detail

Consensus revision (last 18 months)

Analysts covering STAAR Surgical Company

BTIG
Morgan Stanley
Mizuho Securities
Canaccord Genuity
Stifel Nicolaus
Piper Sandler
Needham & Co.
Benchmark Company
William Blair & Co.
Sidoti & Co.
Stephens Inc.
Jefferies & Co.
Benchmark Capital
Oppenheimer

Ratings for STAAR Surgical Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar